SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001847903-23-000081
Filing Date
2023-04-04
Accepted
2023-04-04 17:02:31
Documents
2
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168064212308955.html 4  
1 FORM 4 wf-form4_168064212308955.xml 4 4857
2 POA - DAVID J. GRAINGER ex-24.htm EX-24 5024
  Complete submission text file 0001847903-23-000081.txt   11429
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM CHESHIRE X0 WA14 2DT
Business Address
GRAINGER DAVID J (Reporting) CIK: 0001887115 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 23799033